Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
Mahrukh M. Syeda, Jennifer Wiggins, Broderick C. Corless, Georgina V. Long, Keith T. Flaherty, Dirk Schadendorf, Paul Nathan, Caroline Robert, Antoni Ribas, Michael A. Davies, Jean‐Jacques Grob, Eduard Gasal, Matthew Squires, Mahtab Marker, James E. Garrett, Jan C. Brase, David Polsky
Topics & Concepts
DabrafenibTrametinibMelanomaMedicineCancer researchOncologyMetastatic melanomaVemurafenibBiologyMAPK/ERK pathwayGeneticsPhosphorylationCancer Genomics and DiagnosticsMelanoma and MAPK PathwaysLung Cancer Treatments and Mutations